- Filed
- Nov 12, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 12, 2024 | 1.36M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $19.63M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $28.66M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $340.89K |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $4.28M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $9.71M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $5.53M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $22.28M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $30.53M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $22.83M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $31.11M |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 428.2K sh |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 339.1K sh |
| Capex | Q3 2024 · Sep 30, 2023 | $2.71K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$4.11M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $26.74M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $24.83M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $32.69M |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | $0.84 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | $37.01 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | $0.84 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | $37.01 |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $1.22M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $4.78M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $212.1K |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $1.4M |
| Net Income | Q3 2024 · Sep 30, 2023 | $763.2K |
| Net Income | Q3 2024 · Sep 30, 2023 | −$5.04M |